News for Paradigm Biopharmaceuticals Limited (PAR.AX)

The ASX200 closed up 0.02% at 8,142 points in a flat days trade. Australian shares broke an intra-day record during a volatile day.

Paradigm has confirmed it will use a twice weekly dosage of 2mg/kg injectable pentosan polysulfate sodium in its Phase 3 trial.

The ASX200 started November with a gain of more than three-quarters of a per cent (.85 of a per cent).

ASX morning trade reveals winners, losers; Novonix expands production with $100 million grant

ASX futures were down 0.43 per cent at 8.30 am AEDT as US indexes landed in the red on Friday.

Futures suggest Australian shares will open relatively unchanged in the face of the RBA interest rate decision this afternoon.

NFL Alumni support ex-NFL players with medical symposium during NFL Draft...

The ASX closed in the green, despite teetering around midday after RBA Governor Philip Lowe dampened confidence that interest rates may peak.

Paradigm (ASX:PAR) has claimed a trial of its injectable pentosan polysulfate sodium (iPPS) drug showed the treatment may slow disease progression in knee osteoarthritis (OA).

Paradigm Biopharma said that injectable pentosan polysulfate sodium (iPPS) may slow disease progression in knee osteoarthritis (OA).

The Compleat Guide to ASX Battery Metals Stocks with Automaker Deals, where have all the IPOs gone, and all the data drops before Easter.

ASX closes up following global markets higher as Hubify (ASX:HFY) subsidiary Broadland Solutions inks a new five-year Optus deal.

These are the ASX health stocks who are on the verge of completing Phase III trials. Stockhead reaches out to Cynata's Jolanta Airey.

Sydney, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered...

Sydney, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered...

Sydney, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered...

Sydney, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered...

Sydney, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has...

Sydney, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered...